Moderna disclosed in a securities filing late Friday afternoon that Bancel was among the company executives who had sold shares in the days following its announcement of positive vaccine results in a press release Monday. The price of Moderna's stock, which had been soaring much of this year, jumped 30% on Monday on the news, to an all-time high of $87.
Moderna disclosed that Bancel had sold nearly 17,000 shares on Wednesday in three different transactions at $70 per share. The day's stock sales generated $1.2 million for the CEO.
The company disclosed the stock sales in a filing to the U.S. Securities and Exchange Commission shortly after the market closed for regular trading on Friday afternoon. The company's share price had dropped after the spike on Monday, finishing the week at $69.In all, four of Moderna's top executives netted a total of $30 million in stock transactions in the past few days, including the company's top legal officer, its top scientist and its chief financial officer, the SEC filings show.